Do GLP-1 Patches, Boosters and "Natural GLP-1" Supplements Work? What the Evidence Says
On this page
Published · Last reviewed
Short answer: no good evidence says they do. GLP-1 patches, "GLP-1 boosters" and "natural GLP-1" products are dietary supplements, which the FDA does not approve before sale,[1] and they do not contain a GLP-1 medication.[2] The research on their usual ingredients was done with pills and powders swallowed in far larger amounts, not with skin patches,[2] and the effects measured were small.[3][4]
New to eating less? Start with what to eat when you're eating less, the guide the rest of Lighter Days builds on.
This page is about the products sold as a stand-in for the medication: what is actually in them, why a patch cannot deliver a GLP-1 drug, what the evidence says about each ingredient and the body's own GLP-1, and what regulators have said. If your question is broader, what a "GLP-1" claim on any supplement label means, including vitamins sold to people on the medication, start with what "GLP-1" means on a supplement label.
General information, not medical advice. Do not stop, swap or delay a prescribed medication because of a supplement. Tell your prescriber and pharmacist about anything you take, including patches.
Do GLP-1 patches work? The claims against the evidence
| What the marketing says | What the evidence shows |
|---|---|
| "GLP-1 patch" | Contains no GLP-1 medication. Labels list plant extracts, vitamins and minerals, such as berberine, cinnamon, pomegranate, chromium and glutamine.[2] |
| "Absorbs through the skin" | The ingredients were studied by mouth, not on the skin.[2] A GLP-1 drug is far too large a molecule to cross intact skin.[5][6] |
| "Boosts your natural GLP-1" | Fermentable fiber raised the body's GLP-1 after a meal in a 10-person study, at 16 g a day eaten.[7] The body's own GLP-1 is cleared within minutes; semaglutide lasts about a week.[8][6] |
| Berberine as "nature's Ozempic" | In 23 trials of oral berberine, body weight fell by an average of 0.88 kg more than control.[3] Claims that it mimics a GLP-1 drug are largely unsupported.[9] |
| Green tea extract (EGCG) | Any effect on body weight is small and unlikely to be clinically relevant; concentrated extracts have been linked to liver injury.[4] |
| Chromium | Body weight 0.5 to 1.1 kg lower than placebo in pooled trials, described as of uncertain clinical relevance.[4] |
| Probiotics such as Akkermansia | A 32-person pilot trial; the GLP-1 finding comes from mice.[10][11] |
| "FDA approved" or "clinically proven" | Supplements are not FDA-approved.[1] The FDA has warned a seller of "GLP-1" drops for falsely claiming approval.[12] |
Each row is explained below, with the source.
What is in a GLP-1 patch?
A plant and vitamin blend in an adhesive. A clinician newsletter from the Therapeutic Research Center, which looked at these products in 2025, lists berberine, ginger, glutamine, peppermint leaf, pomegranate and safflower extracts, and states that the patches do not contain GLP-1 medications such as semaglutide.[2]
The patch ingredient panels we checked on November 13, 2026 followed the same pattern: berberine, cinnamon and pomegranate extracts, chromium, L-glutamine and B vitamins. One listed 8.75 mg of berberine and 35 micrograms of chromium per patch, and its old "GLP-1 patch" web address now led to the same product under the name "berberine patch". None listed a GLP-1 drug.
Put the berberine figure next to the research. In the type 2 diabetes trials pooled in a 2012 meta-analysis, people swallowed 0.5 to 1.5 g of berberine a day.[13] That is 500 to 1,500 mg. A patch with 8.75 mg holds less than 2% of the lowest of those daily amounts, and that is before asking how much of it gets through the skin.
"Boosters" and "natural GLP-1" capsules and powders draw from the same short list, plus fibers such as inulin, green tea extract and probiotics. The ingredient-by-ingredient evidence is below.
Can a GLP-1 drug be absorbed through the skin?
Not from a patch you buy online. Skin is built to keep things out, and its outer layer is the main barrier. The working rule in dermatology is that a molecule needs to be under about 500 daltons to be absorbed through skin; every drug used in a skin patch at the time that rule was set out was under that size.[5] Standard skin patches deliver small, fat-soluble drugs needed in small doses.[14]
Semaglutide has a molecular weight of 4,113.58 g/mol, about eight times that limit.[6] Even with a needle, how it is delivered matters a great deal:
- Injected under the skin, about 89% of a dose of semaglutide reaches the blood.[6]
- As the Wegovy tablet, which contains an absorption enhancer called SNAC, about 1% to 2% does.[6] The top tablet dose is 25 mg, against 2.4 mg for the weekly injection.[6]
Getting large molecules such as insulin through skin takes devices that physically breach its outer layer, such as microneedles. As of the 2008 analysis cited here, those were still being tested in clinical trials.[14] A sticker that contains no GLP-1 drug in the first place has nothing of the kind to deliver.
Berberine is a much smaller molecule, so the 500-dalton rule alone does not rule it out. The problem there is different: the research on berberine and the other patch ingredients studied them taken by mouth, not applied to skin.[2] We found no published trial measuring what reaches the blood from these patches.
Can you raise your own GLP-1 naturally?
Yes, a little, and you already do it every time you eat. GLP-1 is a hormone released by cells in the gut lining in response to a meal.[15] The question is whether a supplement can raise it enough, for long enough, to matter. Here the physiology is unforgiving.
The body's own GLP-1 is cleared in minutes. It is broken down by an enzyme, DPP-4, so fast that much of it is inactivated before it even leaves the gut.[15] Given into a vein, native GLP-1 has a half-life of about 1.5 minutes.[8] The medications were engineered around that: semaglutide binds to albumin in the blood and has an elimination half-life of about one week.[8][6] At the 2.4 mg weekly dose it stays in the blood around the clock, at an average steady-state level of about 75 nmol/L.[6] A food or supplement that nudges a meal-time pulse of a hormone that lasts minutes is not doing the same thing.
Fermentable fiber is the best-studied route. Gut bacteria ferment some fibers into short-chain fatty acids, and in cell and mouse studies those fatty acids triggered GLP-1 release from the gut's hormone-secreting cells.[16] In people, the evidence is small:
- In 10 healthy adults, 16 g a day of a prebiotic fiber for two weeks raised GLP-1 and another gut hormone, PYY, after a test meal, and lowered hunger ratings, compared with a placebo powder.[7]
- An engineered compound that delivers the fatty acid propionate to the colon raised GLP-1 and PYY after a meal at 10 g a day.[17] It is a research ingredient, not something in a patch.
Two points follow. These amounts are grams of fiber, eaten, and a patch carries milligrams. And a 2025 joint advisory from four US medical and nutrition societies lists the effect of diet on the body's own GLP-1 as an area still under study, not a settled therapy.[18]
Protein and meals. A meal prompts GLP-1 release whatever is in it.[15] We found no trial showing that a powder or hydrolysate sold for this purpose does something a meal does not. If you are on a GLP-1 medication, the medication is already acting on the same receptor around the clock, far longer than your own hormone lasts.
What does the evidence say about each ingredient?
Berberine
The ingredient sold hardest as "nature's Ozempic". A 2026 meta-analysis of 23 randomized trials of oral berberine found body weight an average of 0.88 kg lower than in control groups, and asked future trials to report purity and dose better and to fix common biases such as missing blinding.[3] A 2026 commentary concluded that its effects are real but limited, and that claims it mimics GLP-1 drugs are largely unsupported.[9] Berberine can also slow liver enzymes that clear many common medicines,[19] so it is a pharmacist question for anyone on other drugs.
Green tea extract (EGCG)
A Cochrane analysis of 14 trials found body weight 0.95 kg lower with green tea preparations than with placebo, but no significant difference in the trials run outside Japan. The NIH Office of Dietary Supplements concludes that any effect is small and unlikely to be clinically relevant.[4] Safety is the bigger point: in a 12-month trial of 1,021 women, a daily extract with 843 mg of EGCG raised liver enzymes, and green tea extracts have been linked to liver damage in at least 50 case reports since 2006.[4] Green tea as a drink has not shown these problems.[4]
Chromium
Pooled trials found body weight 1.1 kg lower than placebo with chromium picolinate, with low-quality evidence and "debatable clinical relevance", and 0.5 kg lower in a second meta-analysis that called the effect of "uncertain" clinical relevance.[4] The patch label quoted above listed 35 micrograms.
Fibers: inulin and others
The most plausible link to the body's own GLP-1, through fermentation, as above.[16][7] Fiber is also worth eating for ordinary reasons, covered below. A gel-forming fiber on top of a medication that already slows the stomach can push fullness further than you want, which is covered in our comparison of fiber supplements on a GLP-1.
Probiotics, including Akkermansia
Akkermansia muciniphila is a gut bacterium. In mice, it secretes a protein that raised GLP-1 secretion.[11] The human evidence is one pilot trial: 40 adults enrolled, 32 finished, and three months of a pasteurized form improved insulin sensitivity, while the change in body weight, −2.27 kg against placebo, was not statistically significant.[10] For probiotics in general, pooled trials show small effects that depend on the strain, dose and person.[4]
Are GLP-1 patches FDA approved?
No. Dietary supplements, including patches sold as supplements, are not approved by the FDA before sale, and they may not be marketed to treat or cure a disease.[1] Semaglutide and tirzepatide are approved as injections, and semaglutide also as a tablet.[6][20] We found no FDA-approved GLP-1 patch as of November 13, 2026.
What regulators have said, as of that date:
- The FDA. In a December 10, 2024 warning letter, the FDA's drug center told an online seller of oral drops promoted under the heading "The Science of GLP-1" that the products were unapproved new drugs and were misbranded, partly because the website said, falsely, that they were FDA approved.[12] Separately, the FDA has warned companies selling unapproved semaglutide, tirzepatide and similar drugs online, and asks consumers to buy GLP-1 medicines only with a prescription from a state-licensed pharmacy.[21]
- The FTC. The Federal Trade Commission's guide for media outlets says nothing worn on the body or rubbed into the skin can cause a substantial change in body weight, and that such claims for patches, creams, wraps and similar products are false.[22] Its health-products guidance expects health claims to rest on randomized human trials, and asks whether the product in the study had the same dose, formulation and way of being taken as the one advertised.[23] A study of an oral capsule does not support a patch.
We found no FTC case or National Advertising Division decision aimed specifically at a "GLP-1" patch as of November 13, 2026. That is an absence of enforcement, not evidence that the products work.
GLP-1 patches: what buyers should know
Before you buy a patch or booster
- Read the panel, not the name. If the product contains no GLP-1 drug, and these do not, "GLP-1" on the front describes the marketing, not the contents.[2]
- Check the milligrams. Compare each amount with what was used in trials. Berberine trials used 500 to 1,500 mg a day by mouth.[13]
- Ask what was studied. A trial of the finished product, worn as sold, is the evidence that counts. Ingredient studies in capsules are not.[23]
- Treat "FDA approved" on a supplement as a red flag. Supplements are not approved before sale.[1]
- Tell your pharmacist. Berberine can change how other drugs are cleared,[19] and green tea extract has been linked to liver injury.[4]
- Read the subscription terms. The patch page we checked defaulted to a monthly auto-ship plan. Know how to cancel before you order.
What actually matters for eating on a GLP-1
If you are on a GLP-1 medication, the hormone side is already handled, by the medication. What it cannot do is choose your food, and a smaller appetite makes every bite count for more. The 2025 joint advisory sets out the priorities:[18]
- Protein first. 1.2 to 1.6 g per kilogram of body weight a day has been proposed for adults on these medications, alongside strength training.[18] The numbers by body weight are in how much protein on a GLP-1, and the protein calculator splits a target into small meals.
- Fiber from food, built slowly. The Dietary Guidelines set 14 g of fiber per 1,000 calories.[24] How to fit that into less food is in how much fiber on a GLP-1, and what to do when things slow down is in fiber and regularity on a GLP-1.
- Fluids on purpose. Normally about a fifth of the water people take in comes from food, so eating less means drinking less too.[25] Daily figures are in how much water to drink on a GLP-1.
- Micronutrients. The advisory lists iron, calcium, magnesium, zinc and vitamins A, D, E, K, B1, B12 and C as nutrients of concern when intake falls.[18] Which supplements are worth considering, and why, is in what supplements to take with a GLP-1.
The full map, one link per question, is our GLP-1 nutrition guide. And if cost or supply is the reason you are looking at patches, that is a conversation for your prescriber, who has dose and medication options a supplement does not.
For transparency about why this page exists on our site: we make one product, Zornava Replenish, a lemon-lime daily hydration and nutrient powder for lighter appetite days, including for people on GLP-1 medications. It is a dietary supplement, not a medication. It does not raise, imitate or replace GLP-1, and it is not an alternative to a GLP-1 medication. It is not on sale yet; early access opens February 9, 2027, and the early-access list is open now.
Frequently asked questions
Do GLP-1 patches work?
No good evidence says so. They contain plant extracts, vitamins and minerals, not a GLP-1 medication, and the research on those ingredients used oral doses, not skin patches. No trial we found tested a finished GLP-1 patch.
Do GLP-1 patches contain semaglutide?
No. The patches contain ingredients such as berberine, cinnamon, pomegranate, chromium and glutamine. Semaglutide, at 4,113.58 g/mol, is also far too large a molecule to pass through intact skin from a patch.
What is natural GLP-1?
A marketing phrase. Your gut makes GLP-1 every time you eat, and it is cleared within minutes. "Natural GLP-1" products claim to raise it with fiber, berberine, probiotics or plant extracts. Evidence for meaningful effects in people is small, and none of it compares with a GLP-1 medication.
What is a GLP-1 booster?
A supplement sold with the claim that it raises the body's own GLP-1. Ingredients are usually fibers, berberine, chromium, green tea extract or probiotics. Supplements are not approved by the FDA before sale and may not claim to treat a disease.
Are GLP-1 patches FDA approved?
No. Supplements are not FDA-approved before sale, and we found no FDA-approved GLP-1 patch as of November 13, 2026. The FDA has warned a seller of "GLP-1" drops whose website falsely claimed FDA approval.
Is berberine the same as a GLP-1 medication?
No. In 23 trials of oral berberine, body weight fell by an average of 0.88 kg more than control, and a 2026 commentary calls claims that it mimics GLP-1 drugs largely unsupported. It can also affect how the liver clears other medicines.
Are GLP-1 patches safe?
The amounts in patches are small, so the main risks are wasted money and putting off treatment that works. Concentrated green tea extract has been linked to liver injury, and berberine interacts with other drugs, so tell your pharmacist about any patch or capsule.
Can I use a GLP-1 patch instead of my prescription?
No. Nothing in a patch acts like the medication. If cost, supply or how you feel on it is the problem, talk to your prescriber, who can adjust the dose or the medication.
References
- US Food and Drug Administration. Questions and Answers on Dietary Supplements. fda.gov. fda.gov. ↩︎
- Therapeutic Research Center (NatMed Pro). Beyond the Hype: GLP-1 Patches. Natural Medicines newsletter. 2025. naturalmedicines.therapeuticresearch.com. Newsletter of September 2025 for clinicians; page read. ↩︎
- Elahi Vahed I, Shahir-Roudi E, Nojumi S, et al. The effect of berberine on obesity indices: a systematic review and meta-analysis. Int J Obes (Lond). 2026;50(1):53–73. PubMed. PMID: 41310257. doi: 10.1038/s41366-025-01943-x. Abstract read. 23 randomized trials of oral berberine. ↩︎
- National Institutes of Health, Office of Dietary Supplements. ods.od.nih.gov. 2022. (sections on green tea, chromium and probiotics) ods.od.nih.gov. Page read in a browser (updated May 18, 2022); the site refuses scripted requests. Sections on green tea, chromium and probiotics. ↩︎
- Bos JD, Meinardi MM. The 500 Dalton rule for the skin penetration of chemical compounds and drugs. Exp Dermatol. 2000;9(3):165–169. PubMed. PMID: 10839713. doi: 10.1034/j.1600-0625.2000.009003165.x. Abstract read. ↩︎
- Novo Nordisk. Wegovy (semaglutide) injection and tablets, prescribing information and Medication Guide. DailyMed, US National Library of Medicine. 2026. (sections 11 and 12.3: molecular weight, bioavailability, half-life, steady-state concentration) DailyMed. ↩︎
- Cani PD, Lecourt E, Dewulf EM, et al. Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal. Am J Clin Nutr. 2009;90(5):1236–1243. PubMed. PMID: 19776140. doi: 10.3945/ajcn.2009.28095. Abstract read. 10 healthy adults; 16 g a day of prebiotic fiber for 2 weeks. ↩︎
- Knudsen LB, Lau J. The Discovery and Development of Liraglutide and Semaglutide. Front Endocrinol (Lausanne). 2019;10:155. Full text. PMID: 31031702. doi: 10.3389/fendo.2019.00155. Full text read (Europe PMC). Both authors were Novo Nordisk employees. ↩︎
- Nona R, Kalo E. Berberine and Metabolic Dysfunction-Associated Steatotic Liver Disease: Hope or Hype? Pharmacol Res Perspect. 2026;14(4):e70300. Full text. PMID: 42458881. doi: 10.1002/prp2.70300. Full text read (Europe PMC). Commentary. ↩︎
- Depommier C, Everard A, Druart C, et al. Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study. Nat Med. 2019;25(7):1096–1103. PubMed. PMID: 31263284. doi: 10.1038/s41591-019-0495-2. Abstract read. Pilot trial; 40 enrolled and 32 completed. ↩︎
- Yoon HS, Cho CH, Yun MS, et al. Akkermansia muciniphila secretes a glucagon-like peptide-1-inducing protein that improves glucose homeostasis and ameliorates metabolic disease in mice. Nat Microbiol. 2021;6(5):563–573. PubMed. PMID: 33820962. doi: 10.1038/s41564-021-00880-5. Abstract read. Mouse and cell study. ↩︎
- US Food and Drug Administration. Warning letter 694688 (Center for Drug Evaluation and Research, December 10, 2024). fda.gov. 2024. fda.gov. Letter read. Issued to an online seller of oral drops; the seller is not named on our page. ↩︎
- Dong H, Wang N, Zhao L, Lu F. Berberine in the treatment of type 2 diabetes mellitus: a systemic review and meta-analysis. Evid Based Complement Alternat Med. 2012;2012:591654. (doses used in the included trials) Full text. PMID: 23118793. doi: 10.1155/2012/591654. (abstract read) ↩︎
- Prausnitz MR, Langer R. Transdermal drug delivery. Nat Biotechnol. 2008;26(11):1261–1268. Full text. PMID: 18997767. doi: 10.1038/nbt.1504. Abstract read. ↩︎
- Holst JJ. The physiology of glucagon-like peptide 1. Physiol Rev. 2007;87(4):1409–1439. PubMed. PMID: 17928588. doi: 10.1152/physrev.00034.2006. (abstract read) ↩︎
- Tolhurst G, Heffron H, Lam YS, et al. Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2. Diabetes. 2012;61(2):364–371. Full text. PMID: 22190648. doi: 10.2337/db11-1019. Abstract read. Cell cultures and mice. ↩︎
- Chambers ES, Viardot A, Psichas A, et al. Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults. Gut. 2015;64(11):1744–1754. PubMed. PMID: 25500202. doi: 10.1136/gutjnl-2014-307913. Abstract read. Used an engineered inulin-propionate ester at 10 g a day. ↩︎
- Mozaffarian D, Agarwal M, Aggarwal M, et al. Nutritional priorities to support GLP-1 therapy for obesity: a joint advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society. Obesity (Silver Spring). 2025;33(8):1475–1503. (sections on protein, fluids, nutrients of concern and areas for research) Full text. PMID: 40445127. doi: 10.1002/oby.24336. ↩︎
- Guo Y, Chen Y, Tan ZR, Klaassen CD, Zhou HH. Repeated administration of berberine inhibits cytochromes P450 in humans. Eur J Clin Pharmacol. 2012;68(2):213–217. Full text. PMID: 21870106. doi: 10.1007/s00228-011-1108-2. (abstract read) ↩︎
- Eli Lilly and Company. Zepbound (tirzepatide) injection, prescribing information and Medication Guide. DailyMed, US National Library of Medicine. 2026. DailyMed. ↩︎
- US Food and Drug Administration. fda.gov. 2026. fda.gov. Page read (content current as of 10/01/2026). ↩︎
- Federal Trade Commission. ftc.gov. 2014. ftc.gov. Page read (January 2014). Claim 7 covers products worn on the body or rubbed into the skin. ↩︎
- Federal Trade Commission. Health Products Compliance Guidance. ftc.gov. 2022. ftc.gov. Page read. Replaces the FTC's 1998 guide for dietary supplement advertising; the page shows no date. ↩︎
- US Department of Agriculture and US Department of Health and Human Services. Dietary Guidelines for Americans, 2020–2025. Office of Disease Prevention and Health Promotion. 2020. odphp.health.gov. ↩︎
- Institute of Medicine. Dietary Reference Intakes for Water, Potassium, Sodium, Chloride, and Sulfate. National Academies Press. 2005. nap.nationalacademies.org. doi: 10.17226/10925. ↩︎
